Summit Therapeutics plc (SMMT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.0600 |
| Open | 4.0800 |
| Bid | 4.3700 x 600 |
| Ask | 4.4000 x 1000 |
| Day's range | 4.0650 - 4.5000 |
| 52-week range | 1.5000 - 5.2200 |
| Volume | |
| Avg. volume | 2,224,364 |
| Market cap | 3.082B |
| Beta (5Y monthly) | -1.20 |
| PE ratio (TTM) | 11.55 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
MIAMI, May 01, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on its operational progress for the first quarter ended March 31, 2024.
- Business Wire
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
MIAMI, April 24, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens.
- Business Wire
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
MIAMI, April 11, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately.
© 2024 Yahoo. All rights reserved.